Latest Resveratrol Stories
AUSTIN, Texas, April 6, 2011 /PRNewswire/ -- Genesis Today, purveyors of one of the country's fastest-growing juice brands and leader in the superfood category, kicked off its "Nourish the Nation" campaign with an initial donation of over $500,000 in superfruit juice to U.S.
AUSTIN, Texas, April 5, 2011 /PRNewswire/ -- Genesis Today, purveyors of one of the country's fastest-growing juice brands and leader in the superfood category, announced today that it has renewed its contract with Maxwell Locke & Ritter LLP, the largest accounting, tax and consulting firm in Central Texas.
IRVINE, Calif., March 30, 2011 /PRNewswire/ -- ChromaDex (OTC Bulletin Board: CDXC) today announced that Nutraceutical International Corporation (Nasdaq: NUTR), one of the nation's largest manufacturers of nutritional supplements, has launched a product featuring ChromaDex's pTeroPure(TM) Pterostilbene in its SolarayÂ® Guaranteed Potency line of products. Solaray Super Resveratrol with Pterostilbene is a product that combines the proven benefits of resveratrol with the high potency,...
GAINESVILLE, Fla., March 23, 2011 /PRNewswire/ -- Clinical studies of Resveratrol--recognized for its proven role in activating the longevity gene to inhibit age-related diseases--have shown that its antioxidant power provides resistance before and after exposure to hazardous radiation. (Logo: http://photos.prnewswire.com/prnh/20110323/CG69998LOGO) Explosions and fires at four nuclear reactors in Japan have created widespread fears about radiation exposure.
The Anti Aging Supplement Review, a blog on anti aging supplements, longevity science, and current news regarding aging, has recently launched a weekly e-mail newsletter.
Researchers from Cleveland Clinic's Lerner Research Institute have discovered that resveratrol â€“ a compound found in red wine â€“ when combined with rapamycin can have a tumor-suppressing effect on breast cancer cells that are resistant to rapamycin alone.
EASTON, Pa., Jan. 31, 2011 /PRNewswire/ -- The Danish Council for Strategic Research has granted $3.4 million for a four year study to investigate resveratrol on the management of metabolic syndrome, osteoporosis and chronic inflammation.
While age-related vision loss of catastrophic proportions is predicted in coming decades, rising from 17 million patients today to 55 million by the year 2050, it's possible this catastrophe could be averted and lost vision even restored using molecular medicine.
Resveratrol, a compound in grapes, displays antioxidant and other positive properties.
It was Paracelsus, the Renaissance physician (1493-1541 A.D.) who first said "the dose makes the poison."